Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers

Peter A. Kavsak; Carolyn S.P. Lam; Amy K. Saenger; Allan S. Jaffe; Paul Collinson; Kari Pulkki; Tobjørn Omland; Guillaume Lefevre; Richard Body; Jordi Ordonez-Llanos; Fred S. Apple

doi:10.1373/clinchem.2019.306621

Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers

Peter A. Kavsak, Carolyn S.P. Lam, Amy K. Saenger, Allan S. Jaffe, Paul Collinson, Kari Pulkki, Tobjørn Omland, Guillaume Lefevre, Richard Body, Jordi Ordonez-Llanos, Fred S. Apple

Cardiovascular Medicine

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1221-1227
Number of pages	7
Journal	Clinical chemistry
Volume	65
Issue number	10
DOIs	https://doi.org/10.1373/clinchem.2019.306621
State	Published - 2019

ASJC Scopus subject areas

Clinical Biochemistry
Biochemistry, medical

Access to Document

10.1373/clinchem.2019.306621

Cite this

Kavsak, P. A., Lam, C. S. P., Saenger, A. K., Jaffe, A. S., Collinson, P., Pulkki, K., Omland, T., Lefevre, G., Body, R., Ordonez-Llanos, J., & Apple, F. S. (2019). Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers. Clinical chemistry, 65(10), 1221-1227. https://doi.org/10.1373/clinchem.2019.306621

Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers. / Kavsak, Peter A.; Lam, Carolyn S.P.; Saenger, Amy K. et al.
In: Clinical chemistry, Vol. 65, No. 10, 2019, p. 1221-1227.

Research output: Contribution to journal › Article › peer-review

Kavsak, PA, Lam, CSP, Saenger, AK, Jaffe, AS, Collinson, P, Pulkki, K, Omland, T, Lefevre, G, Body, R, Ordonez-Llanos, J & Apple, FS 2019, 'Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers', Clinical chemistry, vol. 65, no. 10, pp. 1221-1227. https://doi.org/10.1373/clinchem.2019.306621

@article{b66d709a1a68485da61c56111eb6854a,

title = "Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers",

author = "Kavsak, {Peter A.} and Lam, {Carolyn S.P.} and Saenger, {Amy K.} and Jaffe, {Allan S.} and Paul Collinson and Kari Pulkki and Tobj{\o}rn Omland and Guillaume Lefevre and Richard Body and Jordi Ordonez-Llanos and Apple, {Fred S.}",

note = "Funding Information: Employment or Leadership: P.O. Collinson, The Journal of Applied Laboratory Medicine, AACC; F.S. Apple, Clinical Chemistry, AACC. Consultant or Advisory Role: P.A. Kavsak, Roche, Siemens, Beckman, Abbott; C. Lam, Boston Scientific, Bayer, Roche Diagnostics, AstraZeneca, Medtronic, Vifor Pharma, Novartis, Amgen, Merck, Janssen Research & Development LLC, Menarini, Boehringer Ingelheim, Novo Nordisk, Abbott Diagnostics, Corvia, Stealth BioTherapeutics, JanaCare, Biofourmis, Darma, Applied Therapeutics, WebMD Global LLC, Radcliffe Group Ltd and Corpus; A.S. Jaffe, Beckman-Coulter, Abbott, Siemens, Sphingotec, Brava, Novartis, Medscape; T. Omland, Abbott Diagnostics, Roche Diagnostics; R. Body, Siemens, LumiraDx; J. Ordonez-Llanos, Thermo Fischer; F.S. Apple, HyTest, LumiraDx, Siemens, Instrumentation Laboratory. Stock Ownership: None declared. Honoraria: P.A. Kavsak, Siemens, Beckman, Roche; T. Omland, Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare; J. Ordonez-Llanos, Roche Diagnostics; F.S. Apple, Abbott Laboratories. Research Funding: T. Omland, funding from Abbott Diagnostics and Roche Diagnostics to institution; F.S. Apple, non-salary funding from Abbott, Abbott POC, Beckman Coulter, Siemens, Roche, Ortho Clinical Diagnostics, Qorvo, Becton Dickinson. Expert Testimony: None declared. Patents: P.A. Kavsak, an inventor on patents filed by McMaster University related to laboratory testing in acute cardiac care; specific to heart failure the following patent: US Patent # 8,491,871.",

year = "2019",

doi = "10.1373/clinchem.2019.306621",

language = "English (US)",

volume = "65",

pages = "1221--1227",

journal = "Clinical Chemistry",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry Inc.",

number = "10",

}

TY - JOUR

T1 - Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure

T2 - A report from the IFCC committee on clinical applications of cardiac bio-markers

AU - Kavsak, Peter A.

AU - Lam, Carolyn S.P.

AU - Saenger, Amy K.

AU - Jaffe, Allan S.

AU - Collinson, Paul

AU - Pulkki, Kari

AU - Omland, Tobjørn

AU - Lefevre, Guillaume

AU - Body, Richard

AU - Ordonez-Llanos, Jordi

AU - Apple, Fred S.

N1 - Funding Information: Employment or Leadership: P.O. Collinson, The Journal of Applied Laboratory Medicine, AACC; F.S. Apple, Clinical Chemistry, AACC. Consultant or Advisory Role: P.A. Kavsak, Roche, Siemens, Beckman, Abbott; C. Lam, Boston Scientific, Bayer, Roche Diagnostics, AstraZeneca, Medtronic, Vifor Pharma, Novartis, Amgen, Merck, Janssen Research & Development LLC, Menarini, Boehringer Ingelheim, Novo Nordisk, Abbott Diagnostics, Corvia, Stealth BioTherapeutics, JanaCare, Biofourmis, Darma, Applied Therapeutics, WebMD Global LLC, Radcliffe Group Ltd and Corpus; A.S. Jaffe, Beckman-Coulter, Abbott, Siemens, Sphingotec, Brava, Novartis, Medscape; T. Omland, Abbott Diagnostics, Roche Diagnostics; R. Body, Siemens, LumiraDx; J. Ordonez-Llanos, Thermo Fischer; F.S. Apple, HyTest, LumiraDx, Siemens, Instrumentation Laboratory. Stock Ownership: None declared. Honoraria: P.A. Kavsak, Siemens, Beckman, Roche; T. Omland, Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare; J. Ordonez-Llanos, Roche Diagnostics; F.S. Apple, Abbott Laboratories. Research Funding: T. Omland, funding from Abbott Diagnostics and Roche Diagnostics to institution; F.S. Apple, non-salary funding from Abbott, Abbott POC, Beckman Coulter, Siemens, Roche, Ortho Clinical Diagnostics, Qorvo, Becton Dickinson. Expert Testimony: None declared. Patents: P.A. Kavsak, an inventor on patents filed by McMaster University related to laboratory testing in acute cardiac care; specific to heart failure the following patent: US Patent # 8,491,871.

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85072792010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072792010&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2019.306621

DO - 10.1373/clinchem.2019.306621

M3 - Article

C2 - 31387884

AN - SCOPUS:85072792010

SN - 0009-9147

VL - 65

SP - 1221

EP - 1227

JO - Clinical Chemistry

JF - Clinical Chemistry

IS - 10

ER -

Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this